| Cell line name |
BrE3 |
|---|
| Synonyms |
BrE-3 |
|---|
| Accession |
CVCL_XB11 |
|---|
| Resource Identification Initiative |
To cite this cell line use: BrE3 (RRID:CVCL_XB11) |
|---|
| Comments |
Group: Patented cell line.
Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10028.
Monoclonal antibody isotype: IgG1.
Monoclonal antibody target: UniProtKB; P15941; Human MUC1/CD227. |
|---|
| Species of origin |
Mus musculus (Mouse)
(NCBI Taxonomy: 10090) |
|---|
| Hierarchy |
Parent: CVCL_4032 (P3X63Ag8.653) |
|---|
| Category |
Hybridoma |
|---|
| Publications | PubMed=2365381; DOI=10.1089/hyb.1990.9.221
Jerry A. Peterson, David T. Zava, Axel K. Duwe, Edward W. Blank, Hector Augusto Battifora, Roberto L. Ceriani;
Biochemical and histological characterization of antigens preferentially expressed on the surface and cytoplasm of breast carcinoma cells identified by monoclonal antibodies against the human milk fat globule.
Hybridoma 9:221-235(1990) Patent=US5075219
Roberto L. Ceriani, Jerry A. Peterson;
Monoclonal antibody which recognizes a specific glycoprotein of a human milk-fat globule membrane mucin antigen and said mucin antigen.
Patent number US5075219, 24-Dec-1991 PubMed=8454302; DOI=10.1089/hyb.1993.12.15
Joseph R. Couto, Edward W. Blank, Jerry A. Peterson, Roberto L. Ceriani;
Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody.
Hybridoma 12:15-23(1993) PubMed=7493358
Jerry A. Peterson, Joseph R. Couto, Michael R. Taylor, Roberto L. Ceriani;
Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer.
Cancer Res. 55 Suppl. 23:5847s-5851s(1995) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q93431543
|
|---|
| Entry history |
|---|
| Entry creation | 06-Sep-2019 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 4 |
|---|
